We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Noncardiac Chest Pain and Proton Pump Inhibitors

Ravi K. Bobba, MD; Edward L. Arsura, MD
Arch Intern Med. 2006;166(2):248. doi:10.1001/archinte.166.2.248-a.
Text Size: A A A
Published online


The systematic review and meta-analysis by Wang et al1 focuses on an important issue: assessing the contribution of GERD in noncardiac chest pain (NCCP) by administering short-term, high-dose PPIs. Noncardiac chest pain is a common condition with significant morbidity and economic implications. Unfortunately, the studies included in the meta-analysis were small, and their findings may not be generalizable.

It was not reported by Wang et al1 if the subjective improvement in symptoms of NCCP was followed by an objective evaluation, either additional endoscopic examinations or 24-hour pH monitoring. Another concern is that many patients with NCCP may not have chest pain on a daily basis, because of which ambulatory 24-hour pH monitoring is of limited utility. Because the inclusion criteria for the studies included in the meta-analysis was also based on 24-hour pH monitoring, some patients with infrequent episodes of pain might have been excluded. Considering the cost of 24-hour pH monitoring and its limitations, many experts suggest that 24-hour pH monitoring be reserved for those in whom empirical therapy with a PPI had failed. A number of patients treated with empirical therapy for NCCP will have a placebo response, which may lead to unnecessary and costly long-term therapy. Finally, the study could have been enhanced if evaluation of patients with NCCP included testing to exclude motility abnormalities or the possibility of microvascular angina.2

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
PubMed Articles